Articles tagged "Outcome"

2022 American Transplant Congress
Attitudes Toward Organ Donation in Arab-Based Population
R. A. Almubark¹, M. Alghonaim², N. F. BinDhim³, B. Attar⁴, F. Abaalkhail⁵, F. Al Ammary⁶, S. A. Alqahtani⁷
¹Scientific Department, Sharik Association for Health Research, Riyadh, Saudi Arabia, ²CEO, Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia, ³College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, ⁴Medical Department, Saudi Center for Organ Transplantation, Riyadh, Saudi Arabia, ⁵Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, ⁶Comprehensive Transplant Center, Johns Hopkins University, Baltimore, MD, ⁷Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD
*Purpose: Commitment to organ donation may vary among willing younger and older adults. We aimed to understand attitudes toward organ donation among Arab adults.*Methods: We…
2022 American Transplant Congress
Of the Individual Components of a Modified Freid Frailty Score, Pre-Transplant Walk Time and Grip Strength Are the Strongest Predictors of Post Kidney Transplant Outcomes
S. Parajuli, F. Aziz, H. L. Lorden, K. A. O'Toole, R. E. Wallschlaeger, I. C. Breyer, B. Dodin, J. Goronzik Wang, D. A. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Frailty assessment has become common during evaluation for kidney transplantation; however, a variety of different tools are used for frailty assessment. The Freid frailty…
2022 American Transplant Congress
Thromboelastography in Liver Transplantation: A Target Group
A. Mohamed¹, T. Kitajima¹, J. Cui¹, S. Angappan², K. Delvecchio¹, T. Shamaa¹, T. Ivanics³, S. Shimada¹, M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. Abouljoud¹, J. El-Bashir², S. Nagai¹
¹Henry Ford Transplant Institute, Detroit, MI, ²Henry Ford Hospital, Detroit, MI, ³Surgery, Henry Ford Transplant Institute, Detroit, MI
*Purpose: Liver dysfunction results in derangement of hemostasis and thrombosis. Thromboelastography (TEG) has emerged as a tool to guide resuscitative efforts. However, its utilization and…
2022 American Transplant Congress
Immunomodulation in Lung Transplant May Facilitate Transformation of Usual Interstitial Pneumonia Into Pleuroparenchymal Fibroelastosis
Q. Cai¹, K. Batra², J. R. Torrealba¹
¹Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, ²Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: Pleuroparenchymal fibroelastosis (PPFE) is a rare but distinctive manifestation of interstitial lung disease (ILD) characterized by a highly elastotic pattern of lung fibrosis. Its…
2022 American Transplant Congress
Very Small Pediatric Donors May Help Address the Sex Disparity in Access to Kidney Transplantation
J. Yu, J. Sageshima, M. Nuño, N. Mineyev, N. Goussous, R. Perez
UC Davis Medical Center, Sacramento, CA
*Purpose: Women with end-stage renal disease have lower access to deceased donor kidney transplantation than men. Expanding the donor pool to include kidneys from very…
2022 American Transplant Congress
Prospective Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) in Monitoring Response to Anti-Rejection Treatment in Kidney Transplant Recipients with Indication Biopsy
L. Benning¹, A. Fink², F. Kälble¹, C. Speer¹, C. Nusshag¹, M. Zeier¹, C. Süsal³, C. Morath¹, T. Tran²
¹Department of Nephrology, University Hospital Heidelberg, Heidelberg, Germany, ²Transplantation Immunology, Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany, ³Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a marker of allograft injury in kidney transplant recipients (KTR). Little is known about the possible use of dd-cfDNA…
2022 American Transplant Congress
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
¹Pharmacy, Nebraska Medicine, Omaha, NE, ²College of Pharmacy, University of Nebraska Medical Center, Omaha, NE
*Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…
2022 American Transplant Congress
A Novel Mismatch That Modulates the Innate Alloresponse Risk Stratifies Renal Transplant Patients
H. Dai, K. Abou Daya, M. Oberbarnscheidt, R. Mehta, C. Macedo, D. Metes, Q. Xu, A. Zeevi, P. Randhawa, F. Lakkis, A. Cherukuri
Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA
*Purpose: Donor polymorphism in the gene encoding signal regulatory protein alpha (SIRPα) is a key modulator of the recipient’s innate alloresponse. Here, we investigated the…
2022 American Transplant Congress
Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors
K. Hotta¹, T. Osawa¹, I. Yokota², T. Inao², T. Tanabe¹, N. Iwahara¹, N. Shinohara¹
¹Urology, Hokkaido University Hospital, Sapporo, Japan, ²Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
*Purpose: Previous studies have suggested that living kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general…
2022 American Transplant Congress
Living Related Kidney Donation for Alport Syndrome Spectrum: Long-Term Outcomes
Y. Caliskan¹, A. B. Dirim², S. Safak², B. Yelken³, A. Velioglu⁴, A. Yildiz⁵, O. A. Oto², N. Guller², H. Yazici², A. Ersoy⁵, A. Turkmen³, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Istanbul University, Istanbul, Turkey, ³Koc University Hospital, Istanbul, Turkey, ⁴Marmara University, Istanbul, Turkey, ⁵Uludag University, Bursa, Turkey
*Purpose: Data to guide the evaluation of living related donor (LRD) candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We examined…

« Previous Page
1
…
5
6
7
8
9
…
155
Next Page »